PAFAH1B1, CPTAC-103 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
PAFAH1B1 LIS1, MDCR, MDS, PAFAHA
Sequence Length (AA) Molecular Weight (Da)
410 46638
Protein Name
Platelet-activating factor acetylhydrolase IB subunit alpha
Sources
UniProt PhosphoSitePlus ® GeneCards Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MVLSQRQRDE LNRAIADYLR SNGYEEAYSV FKKEAELDVN EELDKKYAGL
60 70 80 90 100
LEKKWTSVIR LQKKVMELES KLNEAKEEFT SGGPLGQKRD PKEWIPRPPE
110 120 130 140 150
KYALSGHRSP VTRVIFHPVF SVMVSASEDA TIKVWDYETG DFERTLKGHT
160 170 180 190 200
DSVQDISFDH SGKLLASCSA DMTIKLWDFQ GFECIRTMHG HDHNVSSVAI
210 220 230 240 250
MPNGDHIVSA SRDKTIKMWE VQTGYCVKTF TGHREWVRMV RPNQDGTLIA
260 270 280 290 300
SCSNDQTVRV WVVATKECKA ELREHEHVVE CISWAPESSY SSISEATGSE
310 320 330 340 350
TKKSGKPGPF LLSGSRDKTI KMWDVSTGMC LMTLVGHDNW VRGVLFHSGG
360 370 380 390 400
KFILSCADDK TLRVWDYKNK RCMKTLNAHE HFVTSLDFHK TAPYVVTGSV
410
DQTVKVWECR

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for CPTAC-104 Collapse assay details

Data source: Panorama

Official Gene Symbol

PAFAH1B1

Peptide Sequence

TAPYVVTGSVDQTVK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

391

Peptide End

405

CPTAC ID

CPTAC-104

Peptide Molecular Mass

1,563.8144

Species

Homo sapiens (Human)

Assay Type

Direct MRM

Matrix

cell line lysate pool

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

5500 QTRAP (ABSCIEX)

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C,15N

LC

nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)

Column Packing

ChromXP C18-CL, 3 um, 120A

Column Dimensions

150 x 0.075 mm

Flow Rate

500 nL / min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y10 (1+) | 8.8 | 7 | 5 | 10.2 | 8.9 | 8 | 13.5 | 11.3 | 9.4 | 15 | 25 | 15 | | y9 (1+) | 12 | 5.8 | 6.5 | 19.3 | 7.3 | 6.7 | 22.7 | 9.3 | 9.3 | 15 | 25 | 15 | | y8 (1+) | 13.4 | 9.1 | 6.6 | 17.1 | 9.3 | 7.5 | 21.7 | 13 | 10 | 15 | 25 | 15 | | sum | 5.5 | 6.1 | 4.4 | 9.5 | 7.4 | 5.5 | 11 | 9.6 | 7 | 15 | 25 | 15 |



Stability

Data source: Panorama

Fragment ion / Transition control_intra_CV actual_temp_intra_CV frozen_intra_CV FTx1_intra_CV FTx2_intra_CV
Fragment ion / Transition all_intra_CV all_inter_CV

Additional Resources and Comments


Assay Details for CPTAC-103 Collapse assay details

Data source: Panorama

Official Gene Symbol

PAFAH1B1

Peptide Sequence

VWDYETGDFER

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

134

Peptide End

144

CPTAC ID

CPTAC-103

Peptide Molecular Mass

1,415.5994

Species

Homo sapiens (Human)

Assay Type

Direct MRM

Matrix

cell line lysate pool

Submitting Laboratory

Fred Hutchinson Cancer Research Center

Submitting Lab PI

Amanda Paulovich


Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

5500 QTRAP (ABSCIEX)

Internal Standard

peptide

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C,15N

LC

nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)

Column Packing

ChromXP C18-CL, 3 um, 120A

Column Dimensions

150 x 0.075 mm

Flow Rate

500 nL / min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y9 (1+) | 10.1 | 8.2 | 5.4 | 14.2 | 8.1 | 4.7 | 17.4 | 11.5 | 7.2 | 15 | 25 | 15 | | y8 (1+) | 14.5 | 10.2 | 13.5 | 19.5 | 10.4 | 12.6 | 24.3 | 14.6 | 18.5 | 15 | 25 | 15 | | y6 (1+) | 9.8 | 11.3 | 11.4 | 16.4 | 10.2 | 11.7 | 19.1 | 15.2 | 16.3 | 15 | 25 | 15 | | sum | 7.2 | 7.7 | 6.2 | 12.5 | 7.8 | 5.6 | 14.4 | 11 | 8.4 | 15 | 25 | 15 |


Selectivity

Data source: Panorama

Slope of Curve Fit for cell line
fragment_ion HCC1187 HCC1419 HCC1954 HCC70 MCF12A MDAMB175VII ZR751 ZR7530
y6 (1+) -0.87 -0.93 -1.19 -1.15 -0.74 -2.12 -1.33 -4.23
y9 (1+) -0.91 -1.03 -1.38 -1.19 -0.91 -1.68 -1.38 -3.73
y8 (1+) -0.93 -0.8 -1.12 -0.9 -0.78 -1.51 -1.06 -2.72
sum -0.9 -0.95 -1.26 -1.11 -0.84 -1.73 -1.29 -3.54

Stability

Data source: Panorama

Fragment ion / Transition control_intra_CV actual_temp_intra_CV frozen_intra_CV FTx1_intra_CV FTx2_intra_CV
y9 (1+) 2.9 9.4 9.9 NA 6.1
y8 (1+) 4.8 6.3 3 NA 1.8
y6 (1+) 13 5.8 17.3 NA 3.4
sum 4.4 2.8 9.5 NA 2.6
Fragment ion / Transition all_intra_CV all_inter_CV
y9 (1+) 7.5 6.7
y8 (1+) 4.4 4.8
y6 (1+) 9.1 10
sum 4.4 4.5

Endogenous

Data source: Panorama

Fragment ion / Transition intra_CV inter_CV total_CV
y8 (1+) 10 10.1 14.2
y9 (1+) 8.3 8.3 11.7
y6 (1+) 11.5 9.9 15.2
sum 7.7 7.9 11

Additional Resources and Comments